On the 19th March a directive was sent out to the NHS which required them to discharge all patients who they deemed to not require a hospital bed. They declared that transfers from the ward must happen within one hour of that decision being made to a designated discharge area, and that discharge from hospital should happen within 2 hours. NHS trusts were told that “they must adhere” to the new directive.
This directive meant that people who required medical treatment and attention were discharged into Care homes in the thousands.
These were beds that never needed to be made vacant because the number of beds occupied within NHS hospitals during the entirety of the alleged first wave, between April and June 2020 were 30% down on the previous year.
Chris Whitty along with his accomplice Matt Hancock then oversaw the purchase of enough midazolam hydrochloride to cover a normal two years.
This article confirms the purchase and that Whitty and Hancock were looking to purchase much more –
Supplies of the sedative midazolam have been diverted from France as a “precaution” to mitigate potential shortages in the NHS caused by COVID-19, the Department of Health and Social Care (DHSC) has told The Pharmaceutical Journal.
A spokesperson from Accord Healthcare, one of five manufacturers of the drug, told The Pharmaceutical Journal that it had to gain regulatory approval to sell French-labelled supplies of midazolam injection to the NHS, after having already sold two years’ worth of stock to UK wholesalers “at the request of the NHS” in March 2020.
The DHSC said the request for extra stock was part of “national efforts to respond to the coronavirus outbreak”, which included precautions “to reduce the likelihood of future shortages”.
Midazolam is a commonly used drug in palliative care and is considered one of the four essential drugs needed for the promotion of quality care in dying patients in the United Kingdom. Think of it as diazepam on steroids.
Midazolam can also cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing that may lead to permanent brain injury or death.
UK regulators state that you should only receive midazolam in a hospital or doctor’s office that has the equipment that is needed to monitor your heart and lungs and to provide life-saving medical treatment quickly if your breathing slows or stops.
A doctor or nurse should watch you closely after you receive this medication to make sure that you are breathing properly because midazolam induces significant depression of respiration. Your doctor should also be made aware if you have a severe infection or if you have or have ever had any lung, airway, or breathing problems or heart disease.
Midazolam is also used before medical procedures and surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event. It is also sometimes given as part of the anesthesia during surgery to produce a loss of consciousness. But all elective surgeries were cancelled, again under Chris Whitty’s directive, so midazolam was not needed for this purpose....<<<Read The Full Article Here>>>....